These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cold agglutinin disease: where do we stand, and where are we going? Berentsen S; Malecka A; Randen U; Tjønnfjord GE Clin Adv Hematol Oncol; 2020 Jan; 18(1):35-44. PubMed ID: 32511221 [TBL] [Abstract][Full Text] [Related]
8. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392 [TBL] [Abstract][Full Text] [Related]
9. Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease. Michaux L; Dierlamm J; Wlodarska I; Stul M; Bosly A; Delannoy A; Louwagie A; Mecucci C; Cassiman JJ; van den Berghe H Br J Haematol; 1995 Oct; 91(2):421-4. PubMed ID: 8547087 [TBL] [Abstract][Full Text] [Related]
10. Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy. Berentsen S; Beiske K; Tjønnfjord GE Hematology; 2007 Oct; 12(5):361-70. PubMed ID: 17891600 [TBL] [Abstract][Full Text] [Related]
11. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980 [TBL] [Abstract][Full Text] [Related]